For research purposes only. Not for human consumption.
Description:
CJC-1295 with Drug Affinity Complex, commonly abbreviated CJC-1295 DAC, is a synthetic analogue of growth hormone-releasing hormone. It has been modified to resist rapid enzymatic degradation and contains a reactive group designed to form a covalent attachment to circulating albumin.
This albumin-binding characteristic distinguishes the DAC-modified compound from shorter-acting GHRH analogues and has been investigated for its effect on pharmacokinetic persistence and growth-hormone-axis signalling in experimental settings.
CJC-1295 DAC remains a research compound, and published findings should not be interpreted as establishing safety or efficacy for unsupervised human use.
For laboratory research and analytical purposes only. Not approved for human use.
